| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Keriann Little, Craig A Olsson, Sarah Whittle, Jacqui A Macdonald, Lisa B Sheeber, George J Youssef, Julian G Simmons, Ann V Sanson, Debra L Foley, Nicholas B Alle. Sometimes It's Good to be Short: The Serotonin Transporter Gene, Positive Parenting, and Adolescent Depression. Child development. vol 90. issue 4. 2020-04-08. PMID:29094757. |
sometimes it's good to be short: the serotonin transporter gene, positive parenting, and adolescent depression. |
2020-04-08 |
2023-08-13 |
Not clear |
| N A Sinyakova, E Yu Bazhenova, E A Kulikova, D V Fursenko, A V Kuliko. [Effect of the C1473G Polymorphic Variant of the Tryptophan Hydroxylase 2 Gene and Photoperiod Length on the Dopamine System of the Mouse Brain]. Molekuliarnaia biologiia. vol 54. issue 1. 2020-04-06. PMID:32163389. |
a decrease in the light in autumn and winter causes depression like seasonal affective disorders (sad) in sensitive patients, in which the serotonin (5-ht) and dopamine (da) brain mediator systems are involved. |
2020-04-06 |
2023-08-13 |
mouse |
| Darakhshan Jabeen Halee. Targeting Serotonin1A Receptors for Treating Chronic Pain and Depression. Current neuropharmacology. vol 17. issue 12. 2020-04-01. PMID:31418663. |
although functional responses to serotonin are mediated via the activation of multiple receptor types and subtypes, the 5-ht1a subtype is involved in the processing of nociception as well as the pathogenesis and treatment of depression. |
2020-04-01 |
2023-08-13 |
Not clear |
| Darakhshan Jabeen Halee. Targeting Serotonin1A Receptors for Treating Chronic Pain and Depression. Current neuropharmacology. vol 17. issue 12. 2020-04-01. PMID:31418663. |
this article targets the 5-ht1a receptors to show that indiscriminate activation of pre and postsynaptic 5-ht1a receptors is likely to produce no therapeutic benefits; biased activation of the 5-ht heteroreceptors may be a useful strategy for treating chronic pain and depression individually as well as in a comorbid condition. |
2020-04-01 |
2023-08-13 |
Not clear |
| Claudia Lan. Neurochemistry and subjunctivities of depression in Kerala, South India. Anthropology & medicine. 2020-03-31. PMID:32223296. |
the narrative of depression as a neurochemical imbalance in the brain or, more precisely, a deficiency of the neurotransmitters serotonin and norepinephrine - largely produced by commercial interests of the international and national pharmaceutical industry and spread globally by international diagnostic systems - has found its way into the offices of mainstream psychiatrists in kerala. |
2020-03-31 |
2023-08-13 |
Not clear |
| Khadijah S Alexander, Taylor R Rodriguez, Amma N Sarfo, Tadd B Patton, Laurence L Mille. Effects of monoamine uptake inhibitors on pain-related depression of nesting in mice. Behavioural pharmacology. vol 30. issue 6. 2020-03-30. PMID:30724802. |
we hypothesized that the da transporter-selective uptake inhibitor bupropion would block depression of nesting behavior produced by intraperitoneal injection of lactic acid, whereas selective serotonin transporter-selective citalopram, norepinephrine transporter-selective nisoxetine, and the mixed action selective serotonin transporter/norepinephrine transporter inhibitor milnacipran would be ineffective. |
2020-03-30 |
2023-08-13 |
mouse |
| Alice Saul, Bruce Taylor, Steve Simpson, Anne-Louise Ponsonby, Leigh Blizzard, Terence Dwyer, Brendan McMorran, Brenda Wood, Ingrid Af van der Me. Polymorphism in the serotonin transporter gene polymorphisms ( 5-HTTLPR) modifies the association between significant life events and depression in people with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 25. issue 6. 2020-03-19. PMID:29683385. |
polymorphism in the serotonin transporter gene polymorphisms ( 5-httlpr) modifies the association between significant life events and depression in people with multiple sclerosis. |
2020-03-19 |
2023-08-13 |
Not clear |
| Guo-Liang Liu, Yun-Feng Cui, Chang Lu, Peng Zha. Ketamine a dissociative anesthetic: Neurobiology and biomolecular exploration in depression. Chemico-biological interactions. vol 319. 2020-03-16. PMID:32084352. |
ketamine is gaining ground as a potential treating depression because it has a distinct mode of action than typical drugs that influence monoamine neurotransmitters including noradrenaline, dopamine, or serotonin. |
2020-03-16 |
2023-08-13 |
Not clear |
| Dariusz Zurawek, Piotr Gruca, Lucyna Antkiewicz-Michaluk, Marta Dziedzicka-Wasylewsk. Resilient Phenotype in Chronic Mild Stress Paradigm Is Associated with Altered Expression Levels of miR-18a-5p and Serotonin 5-HT Molecular neurobiology. vol 56. issue 11. 2020-03-12. PMID:31098953. |
resilient phenotype in chronic mild stress paradigm is associated with altered expression levels of mir-18a-5p and serotonin 5-ht disturbed serotonergic signaling in the hippocampus observed in many individuals vulnerable to stress has been suggested as one of the primary factors contributing to the development of depression. |
2020-03-12 |
2023-08-13 |
human |
| Silke Pfitzer, Liesel Laubscher, Leith Meyer, Kristin Warren, Rebecca Vaughan-Higgins, Jacobus P Raath, Michael Laurenc. Dose-effect study of the serotonin agonist R-8-OH-DPAT on opioid-induced respiratory depression in blesbok (Damaliscus pygargus philipsi) and impala (Aepyceros melampus). Veterinary anaesthesia and analgesia. vol 46. issue 6. 2020-03-12. PMID:31521514. |
dose-effect study of the serotonin agonist r-8-oh-dpat on opioid-induced respiratory depression in blesbok (damaliscus pygargus philipsi) and impala (aepyceros melampus). |
2020-03-12 |
2023-08-13 |
Not clear |
| Rachel F Schult, Anna J Morris, Lindsey Picard, Timothy J Wiegan. Citalopram overdose and severe serotonin syndrome in an intermediate metabolizing patient. The American journal of emergency medicine. vol 37. issue 10. 2020-03-11. PMID:31257122. |
citalopram is a selective serotonin reuptake inhibitor used for treatment of depression. |
2020-03-11 |
2023-08-13 |
Not clear |
| Lisa B Grech, Ernest Butler, Stephen Stuckey, Robert Heste. Neuroprotective Benefits of Antidepressants in Multiple Sclerosis: Are We Missing the Mark? The Journal of neuropsychiatry and clinical neurosciences. vol 31. issue 4. 2020-03-09. PMID:30945589. |
it is likely that reregulation of the common mechanisms in depression and ms, such as inflammation, serotonin, norepinephrine, glutamate and brain-derived neurotropic factor disruption, and hypothalamic-pituitary-thalamic axis dysregulation, are important to the neuroprotective value of antidepressant medication. |
2020-03-09 |
2023-08-13 |
human |
| Alvaro L Garcia-Garcia, Míriam Navarro-Sobrino, Gila Pilosof, Pradeep Banerjee, Alex Dranovsky, E David Leonard. 5-HT 1A Agonist Properties Contribute to a Robust Response to Vilazodone in the Novelty Suppressed Feeding Paradigm. The international journal of neuropsychopharmacology. vol 19. issue 10. 2020-03-06. PMID:27352617. |
differences in 5-ht 1a receptor function have been implicated in vulnerability to depression and in response to treatment. |
2020-03-06 |
2023-08-13 |
mouse |
| Shengyu Guo, Yan Yang, Xi Jun Pei, Fei Yue Li. Comparative risk of Selective Serotonin Reuptake Inhibitors (SSRIs)-induced nausea among Chinese senile depression patients: A network meta-analysis of randomized-controlled trials. Medicine. vol 99. issue 7. 2020-03-03. PMID:32049832. |
comparative risk of selective serotonin reuptake inhibitors (ssris)-induced nausea among chinese senile depression patients: a network meta-analysis of randomized-controlled trials. |
2020-03-03 |
2023-08-13 |
Not clear |
| M Soiza-Reilly, F J Meye, J Olusakin, L Telley, E Petit, X Chen, M Mameli, D Jabaudon, J-Y Sze, P Gaspa. SSRIs target prefrontal to raphe circuits during development modulating synaptic connectivity and emotional behavior. Molecular psychiatry. vol 24. issue 5. 2020-03-03. PMID:30279456. |
antidepressants that block the serotonin transporter, (slc6a4/sert), selective serotonin reuptake inhibitors (ssris) improve mood in adults but have paradoxical long-term effects when administered during perinatal periods, increasing the risk to develop anxiety and depression. |
2020-03-03 |
2023-08-13 |
mouse |
| Rachel A Daut, Laura K Fonke. Circadian regulation of depression: A role for serotonin. Frontiers in neuroendocrinology. vol 54. 2020-03-02. PMID:31002895. |
circadian regulation of depression: a role for serotonin. |
2020-03-02 |
2023-08-13 |
Not clear |
| Rachel A Daut, Laura K Fonke. Circadian regulation of depression: A role for serotonin. Frontiers in neuroendocrinology. vol 54. 2020-03-02. PMID:31002895. |
stress is a common etiological factor in the development of depression and the circadian system is highly interconnected to stress-sensitive neurotransmitter systems such as the serotonin (5-hydroxytryptamine, 5-ht) system. |
2020-03-02 |
2023-08-13 |
Not clear |
| Daehyuk Jang, Hyun-Ju Lee, Kyungjun Lee, Kyu-Ri Kim, Ran Won, Seung Eun Lee, Insop Shi. White Ginseng Ameliorates Depressive Behavior and Increases Hippocampal 5-HT Level in the Stressed Ovariectomized Rats. BioMed research international. vol 2019. 2020-02-26. PMID:31612144. |
postmenopausal depression is closely associated with depletion of estrogen which modulates transmission of 5-ht, a key neurotransmitter that regulates stress-managing circuits in the brain. |
2020-02-26 |
2023-08-13 |
rat |
| Thanos Emmanue. Remission of treatment-resistant depression with tardive akathisia with electroconvulsive therapy. BMJ case reports. vol 12. issue 9. 2020-02-25. PMID:31537609. |
this report presents a case of drug-induced severe tardive akathisia developing after the combination of a selective serotonin reuptake inhibitor and an antipsychotic, in a woman with severe major depression. |
2020-02-25 |
2023-08-13 |
Not clear |
| Kiran Kumar Katakam, Naqash Javaid Sethi, Janus Christian Jakobsen, Christian Gluu. Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus Acta neuropsychiatrica. vol 31. issue 5. 2020-02-19. PMID:31230598. |
in their second round of critique of our systematic review on selective serotonin reuptake inhibitors for major depression. |
2020-02-19 |
2023-08-13 |
Not clear |